| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |